What Treatment Protocols And Energy Parameters Are Recommended For 1540-Nm Or 1550-Nm Fractional Non-Ablative Lasers For Striae Rubra And Alba?

For striae rubra and striae alba, 1540-nm and 1550-nm fractional non-ablative lasers are generally used in a series of 2 to 6 treatments spaced 2 to 4 weeks apart. Typical settings are 35 to 55 mJ per microbeam with a 10-mm tip or 12 to 14 mJ per microbeam with a 15-mm tip. Another commonly described protocol uses approximately 30 mJ per pulse, a density of 125 to 250 microscopic treatment zones (MTZs)/cm², 8 to 12 passes, and a cumulative session dose of roughly 1.4 to 3.5 kJ.

Fractional non-ablative treatment is primarily a dermal-remodeling strategy: it creates controlled microthermal injury without removing the stratum corneum. Results depend on device-specific energy calibration, treatment density, skin phototype, striae maturity, and the patient’s inflammatory response.

How the Treatment Strategy Works

Why These Wavelengths Are Used

Wavelengths around 1540 to 1550 nm are absorbed predominantly by water in the skin. The laser creates microscopic columns of thermal injury that stimulate fibroblast activity and remodeling of collagen and elastic fibers.

Because the epidermis is largely preserved, these systems generally provide less downtime than ablative fractional lasers. The therapeutic goal is improved dermal thickness, texture, and atrophic appearance, particularly in striae alba.

Treating Striae Rubra

Striae rubra are newer, erythematous stretch marks. A fractional non-ablative laser can be used when dermal texture and atrophy are treatment priorities, but it is not primarily a vascular treatment.

When persistent redness is the dominant concern, vascular-targeted devices such as 585- or 595-nm lasers or IPL are often more directly suited to hemoglobin absorption. Fractional 1540- or 1550-nm treatment may still address the underlying dermal remodeling component.

Treating Striae Alba

Striae alba are older, pale, atrophic stretch marks in which vascular treatments are usually less useful. Fractional non-ablative lasers are used to create dermal microthermal zones and encourage collagen and elastic-fiber remodeling.

Improvement is typically gradual rather than immediate. Several sessions are usually required because neocollagenesis and dermal remodeling continue after each treatment.

Recommended Treatment Protocol

Number and Timing of Sessions

A practical course consists of 2 to 6 sessions, with treatments generally separated by 2 to 4 weeks.

Many protocols use approximately 3 to 5 sessions at 4-week intervals, allowing inflammation to resolve and the remodeling response to develop before repeating treatment.

Energy With a 10-mm Tip

For a 10-mm spot tip, the primary reference recommends approximately:

35 to 55 mJ per microbeam

Higher settings within this range should not be treated as automatically superior. Energy should be selected according to the specific device, treatment level, skin phototype, striae location, prior response, and tolerance.

Energy With a 15-mm Tip

For a 15-mm spot tip, the recommended range is approximately:

12 to 14 mJ per microbeam

A larger tip changes the distribution of energy and treatment coverage, so the 10-mm and 15-mm values should not be compared as though they were interchangeable fluences.

MTZ Density and Passes

An alternative parameter framework uses:

Approximately 30 mJ per pulse
125 to 250 MTZs/cm²
8 to 12 passes
Approximately 1.4 to 3.5 kJ total energy per session

Some broader non-ablative resurfacing protocols describe cumulative doses up to 2 to 6 kJ, but those figures may reflect different body sites, treatment areas, devices, or full-face resurfacing conventions. Total kilojoules should therefore be interpreted in the context of the treated surface area and the manufacturer’s treatment-level system.

How to Adjust the Parameters

Treatment intensity is usually increased progressively when the initial response is well tolerated. The clinician should evaluate erythema, edema, pain, prolonged pigment alteration, and the degree of clinical response before increasing energy or density.

Skin phototype is particularly important. Darker skin types generally require more conservative treatment levels and careful attention to cooling and sun protection because post-inflammatory hyperpigmentation is a meaningful risk.

Comfort and Aftercare

Pre-Treatment Preparation

The skin should be thoroughly cleansed before treatment. Topical local anesthetic is commonly applied to reduce discomfort, with appropriate removal before laser delivery.

Forced-air or contact cooling should be used during treatment. Cooling improves comfort and helps control excessive epidermal heating, although it does not eliminate the need for appropriate energy selection.

Expected Recovery

Typical short-term effects include erythema, edema, mild petechiae, and tenderness. Edema may last approximately 24 to 72 hours, while erythema and petechiae commonly improve over a similar period, although recovery varies by treatment intensity and body site.

The preserved epidermis generally allows faster recovery than ablative resurfacing. Patients should nevertheless be advised that visible improvement in striae develops over weeks to months rather than during the immediate recovery period.

Post-Treatment Care

Apply a bland, hydrating moisturizer several times daily after treatment. Avoid irritating topical products until the skin barrier has recovered according to the treating clinician’s instructions.

Strict sun avoidance and broad-spectrum photoprotection are essential. Ultraviolet exposure can worsen inflammation and increase the risk of post-inflammatory hyperpigmentation, particularly in darker skin phototypes.

Understanding the Trade-offs

Higher Energy Is Not Always Better

Increasing energy, density, or passes may increase dermal heating, but it also increases pain, edema, prolonged erythema, and pigmentary complications. A more aggressive setting can be counterproductive if it causes excessive inflammation or forces treatment delays.

The appropriate endpoint is controlled, tolerable treatment with progressive remodeling, not maximal visible injury.

Device Settings Are Not Directly Interchangeable

A value expressed as mJ per microbeam, mJ per pulse, J/cm², MTZs/cm², or a manufacturer-specific treatment level may describe different aspects of energy delivery. These measurements cannot be converted reliably without knowing the device’s spot geometry, pulse structure, beam profile, and treatment area.

The clinician should use the device-specific protocol and confirm how the manufacturer defines energy, density, passes, and cumulative dose.

Striae Type Influences the Expected Result

Fractional non-ablative lasers address texture and dermal atrophy more directly than redness. Striae rubra may require a separate vascular strategy when erythema is the principal concern, while striae alba may respond more predictably to dermal remodeling but remain difficult to eliminate completely.

Reported clinical improvement ranges broadly, approximately 26% to 75%, reflecting differences in patient selection, striae age, body site, treatment parameters, and assessment methods.

Combination Treatment Requires Judgment

Combining fractional non-ablative treatment with vascular lasers or IPL may be considered when striae rubra have a substantial erythematous component. However, combined treatment can increase cumulative inflammation and should be planned according to skin type, device characteristics, and the patient’s pigmentary risk.

How to Apply This to a Treatment Plan

A reasonable protocol should be individualized within the following framework:

If your primary focus is striae alba: Use fractional dermal remodeling with approximately 35 to 55 mJ per microbeam using a 10-mm tip, or 12 to 14 mJ per microbeam using a 15-mm tip, typically over 3 to 5 sessions spaced about 4 weeks apart.
If your primary focus is striae rubra redness: Assess whether a vascular laser or IPL is more appropriate, while using 1540- or 1550-nm fractional treatment when textural and atrophic remodeling is also needed.
If your primary focus is treatment efficiency: Consider approximately 30 mJ, 125 to 250 MTZs/cm², and 8 to 12 passes, while keeping the cumulative dose within the device- and area-specific protocol.
If your primary focus is minimizing complications: Begin conservatively, use active cooling, space sessions sufficiently, and emphasize moisturization and strict photoprotection.
If your primary focus is treating darker skin: Use lower treatment levels and cautious escalation because post-inflammatory hyperpigmentation risk is more important than pursuing the highest available energy.

The safest effective protocol is the lowest device-validated energy and density that produces consistent remodeling without excessive inflammation or pigmentary complications.

Summary Table:

Parameter	Striae Rubra	Striae Alba
Wavelength	1540 nm or 1550 nm	1540 nm or 1550 nm
Energy (10-mm tip)	35–55 mJ/microbeam	35–55 mJ/microbeam
Energy (15-mm tip)	12–14 mJ/microbeam	12–14 mJ/microbeam
Density	125–250 MTZs/cm²	125–250 MTZs/cm²
Passes	8–12	8–12
Sessions	2–6 (usually 3–5)	2–6 (usually 3–5)
Interval	2–4 weeks	2–4 weeks

Achieve optimal results with BELIS's advanced fractional laser systems, designed for clinics and premium salons. Our 1540nm and 1550nm devices offer precise control for safe, effective striae treatment. Contact us today to learn how our technology can enhance your practice and patient satisfaction. Contact us for a personalized consultation.